Palo Alto Investors’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.2M Sell
1,143,155
-65,413
-5% -$646K 1.55% 22
2026
Q1
$11.7M Sell
1,208,568
-111,942
-8% -$1.03M 1.8% 17
2025
Q4
$12.6M Sell
1,320,510
-3,518
-0.3% -$35.8K 1.76% 16
2025
Q3
$12.9M Buy
1,324,028
+49,275
+4% +$379K 2.39% 15
2025
Q2
$7.74M Sell
1,274,753
-384,981
-23% -$2.89M 1.65% 13
2025
Q1
$20.5M Sell
1,659,734
-78,230
-5% -$1.11M 3.91% 9
2024
Q4
$24.1M Hold
1,737,964
3.73% 10
2024
Q3
$29.1M Buy
1,737,964
+71,586
+4% +$1.54M 3.78% 9
2024
Q2
$34.4M Buy
1,666,378
+2,930
+0.2% +$63.4K 3.99% 9
2024
Q1
$41.2M Buy
1,663,448
+3,391
+0.2% +$101K 4.65% 8
2023
Q4
$60.3M Buy
1,660,057
+2,599
+0.2% +$100K 5.44% 7
2023
Q3
$80M Hold
1,657,458
7.57% 6
2023
Q2
$113M Sell
1,657,458
-6,319
-0.4% -$408K 9.14% 6
2023
Q1
$80.6M Buy
1,663,777
+5,200
+0.3% +$275K 6.68% 8
2022
Q4
$99.9M Buy
1,658,577
+8,800
+0.5% +$515K 8.52% 6
2022
Q3
$100M Sell
1,649,777
-31,700
-2% -$1M 7.91% 7
2022
Q2
$45.7M Hold
1,681,477
3.98% 9
2022
Q1
$61.5M Sell
1,681,477
-3,805
-0.2% -$137K 4.75% 9
2021
Q4
$83.3M Hold
1,685,282
5.32% 8
2021
Q3
$120M Sell
1,685,282
-46,200
-3% -$2.87M 7.25% 6
2021
Q2
$89M Sell
1,731,482
-11,023
-0.6% -$344K 4.91% 9
2021
Q1
$43.8M Buy
1,742,505
+50,700
+3% +$954K 2.49% 15
2020
Q4
$20.3M Buy
1,691,805
+363,071
+27% +$4.29M 1.07% 18
2020
Q3
$13.3M Buy
1,328,734
+557,669
+72% +$6.71M 0.73% 21
2020
Q2
$8.06M Sell
771,065
-4,231
-0.5% -$47K 0.48% 22
2020
Q1
$8.3M Sell
775,296
-217,453
-22% -$2.63M 0.69% 21
2019
Q4
$15.7M Sell
992,749
-11,700
-1% -$125K 0.87% 20
2019
Q3
$7.88M Sell
1,004,449
-104,061
-9% -$924K 0.52% 22
2019
Q2
$11.7M Hold
1,108,510
0.57% 24
2019
Q1
$13.4M Hold
1,108,510
0.56% 24
2018
Q4
$11.4M Buy
1,108,510
+5,185
+0.5% +$61.6K 0.61% 24
2018
Q3
$14.4M Hold
1,103,325
0.58% 24
2018
Q2
$16.1M Buy
1,103,325
+1,987
+0.2% +$39.3K 0.64% 24
2018
Q1
$40.4M Buy
1,101,338
+5,683
+0.5% +$207K 1.73% 18
2017
Q4
$41.1M Hold
1,095,655
1.77% 18
2017
Q3
$71M Buy
1,095,655
+21,700
+2% +$1.33M 2.99% 10
2017
Q2
$58.1M Buy
1,073,955
+18,100
+2% +$964K 2.71% 13
2017
Q1
$58.9M Buy
1,055,855
+62,000
+6% +$3.26M 2.78% 12
2016
Q4
$48.9M Buy
993,855
+59,400
+6% +$3.28M 2.79% 12
2016
Q3
$56M Buy
934,455
+145,837
+18% +$7.82M 3.26% 11
2016
Q2
$27.6M Buy
788,618
+93,100
+13% +$4.05M 2.08% 15
2016
Q1
$28.6M Hold
695,518
2.22% 12
2015
Q4
$47.4M Sell
695,518
-400
-0.1% -$24.1K 2.64% 10
2015
Q3
$31.6M Hold
695,918
1.52% 13
2015
Q2
$36.7M Hold
695,918
1.63% 14
2015
Q1
$26.5M Buy
695,918
+4,700
+0.7% +$121K 1.31% 19
2014
Q4
$14.3M Buy
691,218
+17,400
+3% +$363K 0.84% 26
2014
Q3
$14.9M Buy
673,818
+139,800
+26% +$2.96M 1.12% 24
2014
Q2
$12M Buy
534,018
+1,100
+0.2% +$27.5K 0.9% 29
2014
Q1
$20.4M Sell
532,918
-4,500
-0.8% -$145K 1.69% 17
2013
Q4
$14.3M Buy
537,418
+448,918
+507% +$11.3M 1.33% 20
2013
Q3
$1.79M Hold
88,500
0.19% 29
2013
Q2
$1.14M Buy
+88,500
New +$823K 0.13% 30

Other funds holding PRTA

Palo Alto Investors's PRTA Position: Q2 2026 in Review

Palo Alto Investors reduced its Prothena Corp (PRTA) stake by 5.4% in Q2 2026, selling an estimated $646K and leaving 1,143,155 shares worth $11.2M. The position accounts for 1.55% of the portfolio, ranked #22.

Palo Alto Investors first reported a position in PRTA in Q2 2013 and has held it in 53 quarters since. The position peaked at $120M in Q3 2021. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Palo Alto Investors held 1,143,155 shares of Prothena Corp worth $11.2M as of Q2 2026.
  • Palo Alto Investors sold 65,413 Prothena Corp shares in Q2 2026, an estimated $646K.
  • Prothena Corp made up 1.55% of Palo Alto Investors's portfolio in Q2 2026, its #22 holding.
  • Palo Alto Investors first reported a position in Prothena Corp in Q2 2013 and has held it in 53 quarters since.
  • Palo Alto Investors's Prothena Corp position peaked at $120M in Q3 2021.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Palo Alto Investors's 13F filing for Q2 2026, filed 17 Aug 2026.